| Targeted therapy in advanced non-small cell lung cancer: current advances and future trends U Majeed, R Manochakian, Y Zhao, Y Lou Journal of hematology & oncology 14, 1-20, 2021 | 304 | 2021 |
| The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer JE Berchuck, F Facchinetti, DF DiToro, I Baiev, U Majeed, S Reyes, ... Annals of Oncology 33 (12), 1269-1283, 2022 | 79 | 2022 |
| Immunotherapy in Non-Small Cell Lung Cancer With Actionable Mutations Other Than EGFR K Seegobin, U Majeed, N Wiest, R Manochakian, Y Lou, Y Zhao Frontiers in oncology 11, 750657, 2021 | 54 | 2021 |
| Cavernous hemangioma of the small bowel: a case report and literature review C Durer, S Durer, M Sharbatji, IY Comba, I Aharoni, U Majeed Cureus 10 (8), 2018 | 31 | 2018 |
| Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer N Wiest, U Majeed, K Seegobin, Y Zhao, Y Lou, R Manochakian Frontiers in Oncology 11, 751209, 2021 | 23 | 2021 |
| Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab RW Gao, CN Day, A Bush, AC Amundson, P Prodduturvar, U Majeed, ... Lung Cancer 170, 58-64, 2022 | 18 | 2022 |
| Cell-free tumor DNA dominant clone allele frequency is associated with poor outcomes in advanced biliary cancers treated with platinum-based chemotherapy PLS Uson Junior, U Majeed, J Yin, G Botrus, MB Sonbol, DH Ahn, ... JCO Precision Oncology 6 (1), e2100274, 2022 | 16 | 2022 |
| Circulating cell-free tumor DNA in advanced pancreatic adenocarcinoma identifies patients with worse overall survival G Botrus, PLS Uson Junior, P Raman, AE Kaufman, H Kosiorek, J Yin, ... Frontiers in oncology 11, 794009, 2022 | 14 | 2022 |
| Melanoma metastasizing to the small intestine: a case report illustrating symptomatic and asymptomatic involvement FNU Asad-Ur-Rahman, A Abbass, U Majeed, U Navaneethan Cureus 8 (5), 2016 | 13 | 2016 |
| EGFR/ERBB2 amplifications and alterations associated with resistance to lenvatinib in hepatocellular carcinoma M Lim, JW Franses, R Imperial, U Majeed, J Tsai, D Hsiehchen Gastroenterology 164 (6), 1006-1008. e3, 2023 | 12 | 2023 |
| Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003–2018) K Seegobin, Z Li, M Alhaj Moustafa, U Majeed, J Wang, L Jiang, ... American journal of hematology 97 (9), 1150-1158, 2022 | 12 | 2022 |
| Case Report: Severe back pain, epigastric distress and refractory nausea; an unusual presentation of mediastinal bronchogenic cyst S Ali, A Rauf, LB Meng, Z Sattar, S Hussain, U Majeed F1000Research 7, 2018 | 9 | 2018 |
| Blatchford score is superior to AIMS65 score in predicting the need for clinical interventions in elderly patients with nonvariceal upper gastrointestinal bleed K Abusaada, F Asad-ur-Rahman, V Pech, U Majeed, S Dai, X Zhu, ... Advances in Medicine 2016 (1), 6850754, 2016 | 9 | 2016 |
| Pseudohyperkalemia: to treat or not to treat AG Jain, A Tauseef, SA Hasan, SK Jain, M Wazir, U Majeed Cureus 10 (11), 2018 | 8 | 2018 |
| A rare case of bowel obstruction due to metastatic breast cancer M Sharbatji, S Khalid, M Wazir, U Majeed, AG Jain ACG Case Reports Journal 6 (7), e00144, 2019 | 7 | 2019 |
| Outcomes of COVID-19 in patients with cancer: a closer look at pre-emptive routine screening strategies Z Xie, AN Saliba, J Abeykoon, U Majeed, DR Almquist, ... JCO Oncology Practice 17 (9), e1382-e1393, 2021 | 6 | 2021 |
| A phase II study of atezolizumab (ATEZO) and bevacizumab (BEV) in combination with Y90 TARE in patients (pts) with hepatocellular carcinoma (HCC): Y90+/-BEAT. RV Iyer, M Petroziello, N Parikh, RD Kim, TR Heumann, D Brown, K Kim, ... Journal of Clinical Oncology 41 (4_suppl), TPS629-TPS629, 2023 | 5 | 2023 |
| Macrophage activation led acute heart failure managed successfully with immunosuppression K Seegobin, M Alhaj Moustafa, U Majeed, JC Ray, M Shaikh, L Jiang, ... Journal of Blood Medicine, 1037-1043, 2021 | 5 | 2021 |
| Antibody‐based immunotherapy for treatment of immunoglobulin light‐chain amyloidosis RD Parrondo, U Majeed, T Sher British journal of haematology 191 (5), 673-681, 2020 | 5 | 2020 |
| First Report of Management of Sequential Small Cell Transformation and ALK I1171T Mutation as Resistance Mechanisms in a Patient With ALK-EML4 Fused Non–Small Cell Lung … U Majeed, S Li, K Seegobin, A Nassar, R Manochakian, Y Zhao, Y Lou JTO Clinical and Research Reports 4 (7), 100536, 2023 | 4 | 2023 |
Asad ur RahmanCleveland Clinic FloridaBestätigte E-Mail-Adresse bei ccf.org
